SEC Form 4 · accession 0001209191-17-048604
EAGLE PHARMACEUTICALS, INC. · EGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas L Braunstein
Director
Period of report
Aug 9, 2017
Accepted (ET)
Aug 11, 2017 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 9, 2017 | P | 3,610 | $48.0581 | A | 954,210 | I | See Footnote |
| Common StockF3,F2 | Aug 9, 2017 | P | 15,206 | $49.2081 | A | 969,416 | I | See Footnote |
| Common StockF4,F2 | Aug 9, 2017 | P | 1,584 | $50.0874 | A | 971,000 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $47.67 to $48.665, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (3), and (4) to this Form 4.
- F2These securities are held for the account of certain private investment funds (the "HEC Funds") for which Hudson Executive Capital LP, a Delaware limited partnership ("HEC"), acts as investment adviser. The Reporting Person controls the general partner of HEC and indirectly controls the general partner of the HEC Funds. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in them.
- F3The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $48.73 to $49.58, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $49.815 to $50.39, inclusive.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney